Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Benitec Biopharma Ltd

+ Add to Watchlist

BJ9:GR

0.505 EUR 0.028 5.25%

As of 10:29:13 ET on 01/28/2015.

Snapshot for Benitec Biopharma Ltd (BJ9)

Open: 0.506 Day's Range: 0.505 - 0.570 Volume: 3,380
Previous Close: 0.533 52wk Range: 0.370 - 1.550 1-Yr Rtn: +0.20%

Stock Chart for BJ9

No chart data available.
  • BJ9:GR 0.570
  • 1D
  • 1M
  • 1Y
0.533
Interactive BJ9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BJ9

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -0.0270
Est. PEG Ratio -
Market Cap (M EUR) 58.38
Shares Outstanding (M) 115.60
30 Day Average Volume 2,739
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BJ9

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BJ9

Benitec Biopharma Ltd. is a medical technology research and development Company. The Company's research focuses on the gene-technology field to find ways to fight cancer causing cells. Benitec's research encompasses a gene silencing technology in mammalian cells.

Peter FrenchCEO/Managing DirectorMichael W GrahamChief Scientific Officer
Carl S StubbingsChief Business OfficerDavid SuhySenior VP:Rsch & Dev
More Company Profile & Key Executives for BJ9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil